|
Bhat
Bio-Tech to enter into biopharmaceuticals
The Bangalore-based Bhat Bio-Tech India, specialized in the
design development, manufacture and marketing of diagnostic test
devices plans to foray into biotechnology-based pharmaceutical products
soon.
Matrix,
Medicorp pact to enhance API business
Hyderabad-based Matrix Laboratories Limited and Medicorp Technologies
India Limited (Medicorp) have formed a strategic alliance to establish
a strong presence in the global API (Active Pharmaceutical Ingredient)
business.
Panacea
reworks export strategy
THE
New Delhi-based Panacea Biotech is rethinking its strategy on export
markets and it is learnt that the company is winding up the export
division.
Morepen
finalizes brand acquisition
THE New Delhi-based Morepen Laboratories has finalized the brand
acquisition which the company has been talking for quite sometime.
DRL
files ANDA for clopidogrel bisulfate
Dr Reddy’s Laboratories Ltd (DRL) has filed an Abbreviated
New Drug Application (ANDA) with the US Food and Drug Administration
for clopidogrel bisulfate tablets 75 mg with Para IV certification
on all listed Orange Book patents.
News
Briefs
|
